ArticleBMC complementary medicine and therapies2026
Antiproliferative activity, phytochemistry, network pharmacology, molecular docking and gene expression analysis of Maerua edulis extracts against human cervical cancer cell line.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundMaerua edulis (Gilg & Gilg-Ben.) DeWolf) was traditionally used in the treatment and/ or management of various diseases, including cancer. However, limited studies have evaluated whether M. edulis can suppress the proliferation of cervical cancer cells, and its putative mechanism for antiproliferative activity remains unclear. Therefore, we conducted this study to evaluate the in-vitro antiproliferative and cytotoxic effects of M. edulis root extracts against human cervical cancer cells and their underlying mechanism of action.
methodsTo achieve this goal, we performed MTT assay, microscopic analyses, and wound-healing assay to assess the antiproliferative activity of M. edulis extract and its fractions. Qualitative phytochemical and gas chromatography-mass spectrometry (GC-MS) analyses were performed to characterize the phytochemicals in bioactive extracts, and network pharmacology was utilized to predict putative molecular targets and the mechanism of action of the active extract's fractions. Target validation was accomplished through molecular docking and real-time PCR methods.
resultsBioactive M. edulis extracts exhibited significant antiproliferative activity against HeLa cells, with hexane fraction (essential oil) and ethyl acetate extracts demonstrating IC
conclusionsThe results of our study suggest the potential therapeutic benefits of M. edulis in the treatment and management of cervical cancer. Further in-vivo studies are recommended to validate these findings and establish their safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.